Abstract Type III collagen (Col3), a fibril-forming collagen, is a major extracellular matrix component in a variety of internal organs and skin.
Introduction
Osteoporosis, the most common bone disease in humans, is characterized by low bone mass, deterioration of bone architecture, compromised bone strength and an increase in the risk of fracture [1] . Aging is associated with significant bone loss in women and men. In fact, in developed countries, *50 % of female and 20 % of male quinquagenarians will experience a fracture over the course of their remaining lives [2] . Medical and surgical therapies for osteoporosis, including those which treat sequelae such as fractures, have been estimated to increase health care costs by an estimated $19 billion per year in the United States and are anticipated to escalate, given the expanding elderly population [3] . Three major mechanisms thought to contribute to osteoporosis include insufficient deposition of peak bone mass by late adolescence/early adulthood, inadequate new bone formation during remodeling and excessive bone resorption, particularly beyond the fifth decade of life [1] . Therefore, identification of critical factors which mediate bone deposition early in life is of significant clinical importance for lifelong bone health.
Formation and maintenance of the skeleton requires progenitor cell recruitment, replication and differentiation, processes regulated in part by the extracellular matrix (ECM) [4, 5] . Approximately 90 % of the matrix in bone is composed of collagen, which serves as a tissue scaffold but also provides a substrate for cell anchorage and regulates bioavailability of growth factors and cytokines. Type III collagen (Col3), a homotrimeric fibril-forming collagen, is found mainly in extensible tissues such as blood vessels, skin and lung [6] [7] [8] in heterotypic fibrils with type I collagen (Col1) [9, 10] . A small amount of Col3 is also present in Col1-containing fibrils in bone [11] [12] [13] . A critical role for Col3 in skeletal development is suggested by its appearance in mesenchymal condensations preceding cartilage and bone formation [14] , its requirement for growth acceleration of osteoblasts [15] and its possible role in preserving osteogenic potential of mesenchymal stem cells [16] .
Vascular Ehlers-Danlos syndrome (EDS) is a dominantly inherited connective tissue disorder caused by mutations in the Col3 gene. Individuals with vascular EDS experience significant morbidity and mortality as a result of rupture of large vessels. They also exhibit skeletal manifestations, including a distinctive facial appearance, spinal deformity, scoliosis and osteoporosis [17] [18] [19] . However, the mechanisms mediating the effects of Col3 on skeletal development are unknown.
Recognizing this potential role for Col3 in development and maintenance of the skeleton, our objective was to use mice deficient in Col3 [20] to investigate the important role of this protein in craniofacial and skeletal development. The data presented herein support our hypothesis that Col3 plays a positive role in development of trabecular bone through its effect on osteoblastogenesis.
Materials and Methods

Production and Genotyping of Col3-deficient Mice
Animal utilization and care were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Pennsylvania and followed guidelines set forth in the National Institutes of Health Guide for the Care and Use of Laboratory Animals. All mice for this study were generated in a colony established at the University of Pennsylvania from breeder pairs of Col3A1 heterozygous (Col3 ?/-) mice originally purchased from Jackson Laboratories (Bar Harbor, ME, USA). These mice had been generated by homologous recombination by replacement of the promoter region and first exon of the Col3 gene with a 1.8 kb PGKneo cassette [20] . Animals were genotyped for Col3 by PCR analysis of DNA extracted from tail biopsy samples as described previously [21] . At the time of genotyping, mice were microchipped for identification (Allflex FDX-B transponders, Allflex USA Inc., Dallas, TX, USA). All mice were identified on the basis of the last four digits of the implanted microchip so that analysis was performed in a blinded fashion with respect to genotype of the individual, as previously described [21] . Mice were humanely killed by CO 2 asphyxiation followed by cervical dislocation, in accordance with current AVMA guidelines on euthanasia. Femora and tibiae were removed, and the majority of soft tissues were removed from the bone specimens immediately after death. Whole bone specimens were wrapped in gauze and stored at 4°C in 4 % paraformaldehyde before microcomputed tomographic (lCT) imaging.
Bone mRNA Expression Analysis
Hind limbs were removed from young (10.4 ± 0.7 week; mean ± SD) and aged (92.6 ± 1.5 week) female Col3
and Col3
?/-mice (n = 3-4 for each group), and muscle was removed from the femora and tibiae. The bones were stored in RNAlater (Life Technologies, Carlsbad, CA, USA) at -20°C. Before RNA extraction, bones were flash frozen in liquid nitrogen and ground with a mortar and pestle cooled with dry ice. Total RNA was isolated from the resultant powdered tissue using QiaShredder and RNeasy Mini kits (Qiagen, Venlo, Netherlands). RNA concentration was quantified, and 300 ng was subjected to single-strand reverse transcription using the Superscript III First-Strand Synthesis System (Life Technologies). The resultant cDNA was utilized for real-time PCR with oligonucleotides that were specific for Col3 ( 
Microcomputed Tomography
The quantitative analysis of trabecular bone at the distal femoral metaphysis was performed using a vivaCT 40 system (Scanco Medical, Switzerland; http://www. scanco.ch/) at a voxel resolution of 10 lm per slice, and at least 100 slices were morphed. Each scan was performed at 55 keV and 145 lA with an integration time of 200 ls. Images were thresholded to distinguish bone from nonbone voxels using a custom edge-detection algorithm. The region of interest analyzed for each femur was 20 slices obtained 50 lm (5 slices) from the primary spongiosum in the metaphyseal region. Morphometric parameters defining trabecular bone mass and microarchitecture, including bone volume fraction (BV/TV), trabecular thickness (TbTh) and separation (TbS), structural model index (SMI), and connectivity density (ConnD) were calculated.
Cranial Morphometric Analysis
Three-dimensional reconstructions of skull lCT images were used to obtain distances between previously established developmental craniofacial landmarks [22] . Briefly, the distance between (1) the nasion to the bregma, (2) the nasion to the intersection of parietal and interparietal bones, (3) the joining of the squamosal body to the zygomatic process of the squamosal and the intersection of the parietal, temporal and occipital bones and (4) the distance between the intersection of the parietal, temporal and occipital bones on the right and left side of the skull were calculated in 6-week-old wild-type and heterozygote mice.
Mesenchymal Progenitor Isolation and Alkaline Phosphatase (AP) and Mineralization Assays Mesenchymal progenitors were isolated from e18.5 embryos as previously described [23, 24] to allow comparison of differentiation capacity of Col3 wild-type and null cells. Cells were expanded in culture to generate sufficient numbers. Subconfluent cultures were passaged and replated at a density of 1.8 9 10 4 cells/cm 2 in DMEM supplemented with 10 % fetal bovine serum (FBS; Atlanta Biologicals, Inc., Lawrenceville, GA, USA), 100 U/ml penicillin, 100 lg/ml streptomycin (Sigma, St. Louis, MO, USA) and 100 lg/ml of L-ascorbic acid 2-phosphate (Asc; Sigma, St Louis, MO, USA). The cells were incubated in this growth media at 37°C in a humidified 5 % CO 2 atmosphere, as previously described [25, 26] . Early passage cells were used (\P10) for all experiments. Cells were isolated from five different embryos of each genotype for analysis.
AP activity assays were performed as previously described [26] . Briefly, cells were seeded in growth media at an initial plating density of 3.4 9 10 4 cells/cm 2 . After 24 h, growth media was replaced with fresh media with or without 100 ng/ml of BMP6 (R&D Systems, Minneapolis, MN, USA) and 100 lg/ml of Asc. The media was changed every 2-3 days. 6 days after induction, cultures were collected and assayed for AP activity, which was normalized to the number of viable cells per well as determined by the use of a tetrazolium (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium [MTS]) assay as previously described [26] .
For longer-term osteogenic cultures, cells were plated at a slightly lower initial density (0.54 9 10 4 cells/cm 2 ). Staining with Alizarin red S was performed on day 14 after osteogenic induction. For staining, cells were washed with PBS once, rinsed with 50 % EtOH for 3 min, stained with 1 % w/v Alizarin red S in 0.01 % ammonium hydroxide for 10 min at room temperature and washed with deionized water three times. Images of control and osteogenic cultures were obtained before semiquantitative analysis of mineralization, as described previously [27] . Briefly, Alizarin red S was released from the cell matrix by incubating with 10 % cetylpyridinium chloride in 10 mM sodium phosphate (pH 7.0) for 30 min (Sigma). The concentration of released Alizarin red S was determined by measuring the absorbance at 562 nm with Varioskan Flash (Thermo, West Palm Beach, FL, USA).
Assessment of Osteoclast Numbers
Osteoclasts were identified by positive staining for tartrate resistant acid phosphatase (TRAP) activity using the Acid Phosphatase, Leukocyte (TRAP) kit (Sigma), following the manufacturer's instructions. Histologic sections were obtained from an unpublished simple closed transverse tibial fracture study in young adult female Col3
?/? (n = 7) and Col3
?/-(n = 6) mice. Bones had been fixed in 4 % PFA and subsequently decalcified in 15 % formic acid overnight, then processed for paraffin embedding and sectioned. Paraffin was removed with xylene, and sections were rehydrated in decreasing concentrations of ethanol. For each sample, osteoclasts were counted in one 2009 field of the proximal tibia, not including the growth plate or associated with an intramedullary pin tract, and the bone surface perimeter was traced and quantified using ImageJ.
Data Analysis
Values are expressed as mean ± standard deviation (SD) in the text and figures, unless otherwise stated. Unpaired Student's t tests were used to determine the significance of differences between genotypes. Study groups were compared by SigmaPlot software (Systat Inc., Chicago, IL, USA). Nonparametric analyses used the Shapiro-Wilk test for normality and the Mann-Whitney rank sum test; p values of \0.05 were considered statistically significant.
Results
Consistent with previous reports, we observed rare (\1 %) survival of Col3
-/-mice beyond the early perinatal period. In contrast, Col3
?/-mice survived and were weaned without incident and grew at a rate comparable to wild-type mice (mean ± SD weight of female Col3
?/? and Col3
?/-mice at 10 weeks: 20.87 ± 1.54 and 19.78 ± 0.84 g, respectively). As previously reported for other tissues, Col3 expression in bones of young Col3 ?/-mice was approximately half of that found in wild-type mice (Fig. 1) . However, a dramatic reduction in Col3 mRNA expression occurs in aged mice, consistent with the decreased Col3 described in other tissues during aging [28] [29] [30] [31] [32] . Mice of both genotypes were found to have Col3 mRNA expression at levels of \10 % of that seen in young wild-type mice.
Although Col3 heterozygous mice were initially reported to be phenotypically normal, more recent reports suggest that Col3 haploinsufficient mice develop pathology consistent with that seen in human patients with vascular EDS [33] . Because facial dysmorphy is a common clinical feature of vascular EDS in human patients, we quantitatively assessed craniofacial phenotype in young adult Col3
?/? and Col3 ?/-littermates. This technique has previously been used to establish parallels in craniofacial maldevelopment between murine models and their respective human counterparts [22] . Four distinct linear measurements in the rostrocaudal and mediolateral axes were obtained using the rendered lCT images from Col3
?/ ? and Col3
?/-mice ( Fig. 2a-c) . Rostrocaudal length between either the nasion (#1 in Fig. 2a ) or the bregma (#2) and the intersection of the parietal and interparietal bones (#3) were not significantly different between mice of either genotype. Additionally, no differences in length were found between the joining of the squamosal body to zygomatic process of squamosal (#4) and the intersection of parietal, temporal and occipital bones (#5). Furthermore, there was no difference in mediolateral length from the intersection of the parietal, temporal and occipital bones on the left side of the skull to this same point on the right (#5-6). Although no differences were noted in the cranial morphometrics analyzed in Col3 haploinsufficient mice and their wild-type counterparts, it was noted that the skull of a Col3 -/-mouse, which survived to adulthood, appeared shortened in the craniocaudal direction (Fig. 2a) . Also of particular interest was the finding of altered morphology and density of the mandibular condyle in the Col3 -/-mouse (Fig. 2c) , consistent with temporomandibular joint disease found in human patients with vascular EDS [17] .
Col3-deficient Mice Have Significantly Reduced Trabecular Bone
Survival of Col3
-/-mice to adulthood was extremely rare. In light of a previous report of juvenile osteoporosis in a young patient with vascular EDS [19] , we investigated the effect of Col3 deficiency on bone mass in two available 
Col3
-/-mice that survived until 6 weeks of age (one male, one female) and compared them to sex-and age-matched littermates (Fig. 3) . The lCT images show a dramatic decrease in trabecular bone mass in the distal femur of young adult Col3 -/-mice compared to wild-type littermates. Heterozygous mice appeared to have an intermediate phenotype. In contrast to the noted changes in trabecular geometry, no significant differences in cortical bone geometry were noted between adult female Col3
?/-mice (data not shown). In addition, femoral length was not significantly different between young adult female Col3
?/? and Col3 ?/-mice (14.1 ± 0.94 vs. 13.71 ± 1.28 mm, respectively).
To further define the effects of Col3 deficiency on appendicular skeletal modeling and remodeling, we used lCT to assess distal trabecular bone of femurs isolated from both young and middle-aged (12-month-old) nulliparous female Col3
?/-mice. lCT morphometric analysis revealed a significant reduction in BV and BV/TV in both young and aged Col3
?/-mice relative to controls ( Fig. 3b ; Table 1 ). In addition, ConnD was decreased in Col3 heterozygous samples from young female mice compared to wild-type mice, suggesting that trabeculae are less connected ( Fig. 3 ; Table 1 ). As expected, a reduction in ConnD was seen in older wild-type mice compared to younger mice, although no significant differences in ConnD were observed between older female mice of the two genotypes.
SMI was also significantly increased in distal femurs of the young heterozygote female mice compared to wild-type mice (Table 1) , suggesting the trabecular structure in Col3 haploinsufficient mice is more perforated or rodlike (Table 1) . Although not statistically significant (p = 0.06), a similar trend was seen in aging mice ([1 year). A small, but significant reduction in TbTh in young Col3
?/-female mice compared to wild-type littermates was also found. An increase in TbTh was noted in the older group of female mice compared to younger mice, although no significant effect of Col3 on TbTh was seen in female mice more than 1 year of age. Similar trends were noted for BV/TV, ConnD, SMI and TbTh in a small number of young male mice examined (n = 4 for each genotype); however, these values were not statistically significant. Because these data were not sufficiently powered, conclusions regarding the effect of sex in modulating Col3 effects in bone cannot be made. The decision to pursue larger numbers of female mice was based on the established relationship between females and osteoporosis and the practical reason that female mice could be aged in grouped housing with greater ease (lack of fighting).
Fig. 2 Effects of Col3 deficiency on craniofacial morphometry. a Dorsal views of three-dimensional reconstructions of skull lCT images of 6-week-old Col3
?/? and Col3 ?/-mice were used to obtain distances between previously established craniofacial landmarks, labeled 1-6 in left panel [21] . The skull of a Col3 -/-mouse appears shortened in the craniocaudal direction. 
Osteoblastogenesis is Reduced in Mesenchymal Progenitors from Col3-deficient Mice
Previous studies have suggested that Col3 plays a positive role in regulating osteoblastogenesis [15] . To explore potential mechanisms by which an absence of Col3 may regulate bone mass, we compared the effect of Col3 on osteogenesis and osteoclast activity. To first investigate the hypothesis that Col3 is critical for osteogenesis, we examined the ability of wild-type and Col3-deficient mesenchymal progenitors to undergo osteogenesis and produce a mineralized matrix in vitro. Mesenchymal progenitors from five Col3
?/? and Col3 -/-embryos each were utilized for assessing AP activity and mineralization in longer-term cultures (day 14), as described in Materials and Methods. As anticipated, cultures of wild-type mesenchymal , Col3
?/-and Col3 -/-mice of both sexes and nulliparous 12-month-old female Col3
?/? and Col3 ?/-mice progenitors exposed to appropriate inducers had high levels of AP activity (Fig. 4a ). There were not significant differences in MTS activity (used to normalize cell numbers between cultures) between cells of the two genotypes (data not shown). Although AP activity was significantly elevated in Col3 -/-mesenchymal progenitor cultures under osteogenic conditions compared to noninducing conditions, the response of these cells was dramatically diminished (\10 %) compared to that seen in cultures of Col3
?/? cells (p \ 0.02). Similarly, although Col3
?/? mesenchymal progenitors underwent efficient mineralization when cultured in the presence of appropriate inducers, cultures of Col3 -/-cells under osteogenic conditions exhibited relatively poor mineralization, as evidenced by Alizarin red staining (Fig. 4b) . When Alizarin red was extracted and quantitated, there was a significant reduction (p \ 0.01) in mineralization of cultures of Col3 -/-cells relative to those of Col3
?/? cells (Fig. 4c) . The lack of Col3 in the matrix does not appear to prevent mineralization completely, however, because cultures of Col3
-/-cells do show an increase in mineralization under osteogenic conditions, albeit a much smaller increase than wild-type cells. Next, we examined expression of the osteogenic markers Col1, BSP and OCN in long bones of our young and aged mice (Fig. 4d) . Reduction in all three markers is noted in Col3
?/-mice relative to wild-type mice, with a further decline evident with age. Finally, to determine whether decreased trabecular bone density could be mediated by increased osteoclast activity in Col3 deficient mice, TRAP was performed on the distal proximal tibia of young adult female Col3
?/? and Col3 ?/-mice. Interestingly, these data revealed a small but significant decrease in osteoclast frequency in Col3
?/-mice compared to Col3 ?/? mice ( Fig. 5 ; p \ 0.05).
Discussion
The ECM plays an essential role in directing cellular activities during development, maintenance and repair of the skeletal system in part through its ability to act as a scaffold. In addition, the ECM also directly regulates cell behaviors such as migration, differentiation, proliferation, and survival through its ability to engage adhesion receptors, as well as its ability to regulate growth factor bioavailability and signaling [34] . More recently, a key role for mechanical control of cell fate through interaction with the ECM has emerged [35] . Col3 has been suggested to play important roles in development and in tissue repair and regeneration as a result of its increased expression in embryonic relative to postnatal tissues, as well as its increased expression early in the repair process of a variety of tissues and organs [36] [37] [38] .
Despite the fact that Col3 is among the most abundant collagens in tissues, relatively little is known about how this collagen directs key aspects of development and tissue maintenance and repair. A Col3-deficient mouse, which recapitulates many features of vascular EDS in humans, has been used by several investigators to examine the role of Col3 in these processes. Liu et al. [20] had previously established a critical role for Col3 in cardiovascular development through its ability to regulate Col1 fibrillogenesis. More recently, Col3 was shown to contribute to maintenance of vascular integrity, as the aortas of aged Col3 heterozygote mice develop a spectrum of lesions similar to those observed in human vascular EDS patients [33] , in a process that appears to be regulated by increased tissue gelatinase activity [39] . Finally, Col3 has been shown to regulate proper lamination of the cerebral cortex by its ability to control neuronal migration in the developing brain through its interaction with the G-proteincoupled receptor, GPR56 [40] .
Col3 has been shown to be present in the mesenchymal condensations that precede chondrogenesis and osteogenesis [14] and in marrow stroma that serves as a reservoir of osteoprogenitor cells [41] [42] [43] ; however, whether Col3 is present in mature bone is controversial. Early studies reported that Col3 disappears altogether from mature bone [44, 45] ; however, recent studies with more sensitive techniques have reported that Col3 persists into maturity in trabecular bone [42] and as extensions of fibers connecting periosteum to bone [12, 46, 47] . Col3 expression in nonosseous tissues has been shown to decline with age; this decline has been suggested to correlate with decreased regenerative capacity [28] [29] [30] [31] [32] . These results are consistent with our expression data showing a significant reduction in bone Col3 with advanced age (Fig. 1 ). An approximate 50 % reduction in Col3 expression in the bone of agematched young heterozygote mice is consistent with previously reported Col3 expression in other tissues in these mice [20, 33, 48] .
Although the major clinical signs that lead to diagnosis of vascular EDS include rupture of large vessels and the gastrointestinal or urogenital tracts, individuals with this condition have also been described to display numerous skeletal manifestations, including osteoporosis, as well as a distinctive facial appearance, spinal deformity, scoliosis and temporal mandibular disorder [17] [18] [19] . Distinctive facial features in vascular EDS patients include thin lips and philtrum, small chin, thin nose and large eyes [49] . The skull of one Col3 homozygous null (Col3 -/-) mouse was available that suggested shortening in the cranial-caudal direction (Fig. 2) ; however, the small number of null mice that survived to weaning precluded statistical analysis. Craniofacial morphometrics using four previously defined measurements for establishing parallels in craniofacial maldevelopment between murine models and their respective human counterparts failed to show any differences between Col3
?/? and Col3 ?/-littermates, suggesting either that the same features are not evident in this murine model or that the haploinsufficient state is not severe enough to cause morphometric abnormalities in these craniofacial bones. Of interest was the noted defect in the surface of the mandibular condyle in one Col3 -/-mouse (Fig. 2c ) because temporomandibular joint disorder is commonly found in EDS patients, including those with the vascular form of the disease [17] . In addition to being a component of bone, Col3 is also a constituent of the collagenous matrix of the other structural components of the temporomandibular joint, including the fibrocartilage, supporting ligaments, disc and retrodiscal tissues [17] .
Although craniofacial dysmorphism associated with Col3 deficiency was not established in Col3
?/-mice, the finding of diminished trabecular bone geometry in young mice ( Fig. 3 ; Table 1 ) correlates with a previous report of juvenile osteoporosis in a 10-year-old vascular EDS patient [19] . Reduction in Col3 has previously been associated with an osteoporotic state [50] , although whether Col3 deficiency contributed to or was the result of bone loss was not established. A significantly diminished bone volume fraction (BV/TV) in Col3
?/-mice compared to wild-type littermates by 6-8 weeks of age suggests that Col3 plays an important role in establishing early accumulation of bone. Significant reduction in bone volume fraction was sustained in mice as they aged (over 1 year). A previous study examining bone density in Balb/c mice established that a significant decline in bone volume fraction is not seen until 20 months of age [51] . Because the older mice used in this study were of middle age (*1 year old), conclusions cannot be drawn whether Col3 deficiency exacerbates ageassociated osteoporosis. The distal femurs from only two Col3 -/-mice were available for analysis; however, the severity of trabecular bone loss evident on lCT suggests that the negative impact of Col3 loss on trabecular bone density is dose dependent (Fig. 3) .
In contrast to the effect of Col3 on trabecular bone density, there were no apparent differences in cortical bone geometry, at the level of the femoral middiaphysis, between Col3
?/? and Col3 ?/-mice (data not shown). Because cortical bone forms by a process resembling intramembranous bone formation, these results suggest that intramembranous bone is less severely affected than bone that is formed via endochondral ossification in Col3-deficient mice. This interpretation is also supported by the lack of evidence of significant craniofacial abnormalities in Col3
?/-mice because the majority of craniofacial bones develop via an intramembranous process. It should be noted that calvarial bone density was not assessed in our study.
Our results suggest that Col3 plays a role in trabecular bone formation and maintenance through its direct effect on osteogenesis, as supported by our in vitro and in vivo analysis of osteogenesis (Fig. 4) . Furthermore, our data examining osteoclast numbers by TRAP staining did not reveal a proresorption phenotype associated with Col3 loss. In fact, the small but significant decrease in osteoclast numbers in Col3
?/-is likely a result of diminished osteogenesis, as these processes are well established to be coupled [52] . Col3 has been shown to play a structural role in tissues [20] , and the severity of the defects observed in skeletal development in the complete absence of Col3 could be due to altered collagen fibril architecture. However, two additional mechanisms by which Col3 may regulate cell fate and activity in tissue repair and maintenance have been proposed and are of relevance to bone, including regulation of bioavailability of members of the TGFb family of growth factors, including bone morphogenetic proteins (BMPs) [21, 53, 54] or integrin expression [55] . Either or both of these mechanisms could alter the fate of mesenchymal progenitor cells, for example, by b Fig. 4 ?/? and Col3 ?/-femora and tibiae (samples identical to those used in Fig. 1 to establish Col3 expression). Col1, OCN, and BSP expression are presented relative to that in young Col3
?/? mice (n = 3-4 for each group). GAPDH expression was used as the endogenous control. For comparisons to young Col3
mice,*p \ 0.05 and **p \ 0.01, and comparisons between other groups, p \ 0.05, via 1-way ANOVA followed by Tukey post hoc test ?/-bones relative to Col3
?/? mice. Osteoclast number was analyzed by positive TRAP staining in young female Col3
?/? (n = 7) and Col3 ?/-(n = 6) proximal tibiae. Osteoclast number was normalized to the length of bone surface within the image field. Comparison of osteoclast density revealed a significant decrease in these cells in Col3-deficient bones relative to wild-type mice (*p \ 0.05, between Col3
?/-mice)
blocking their differentiation at an early stage or inducing an alternative differentiation path.
